Notes to the Group annual financial statements for the year ended 31 May 2026

1. RESULTS OF OPERATIONS
   1. Segmental summary
   2. Revenue
   3. OPERATING (LOSS)/ PROFIT
   4. Finance costs and finance income
   5. Earnings per share
   6. Cash generated by operations
2. GROUP COMPOSITION
   1. Investments in and loans to associates and joint ventures
   2. INVESTMENT IN CELL C
   3. (B) ASSESSMENT OF INVESTMENT IN ASSOCIATES AND JOINT VENTURES FOR IMPAIRMENT
   4. Non-controlling interests
   5. Interest in subsidiaries, associates and joint ventures
3. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT
   1. Financial instruments
   2. Financial risk management
   3. Financial assets
   4. Financial liabilities
   5. Financial instruments at fair value through profit or loss
   6. LEASES
4. NON-FINANCIAL INSTRUMENTS
   1. Goodwill
   2. Intangible assets
   3. Property, plant and equipment
   4. Right-of-use assets
   5. Inventories
   6. Deferred revenue
5. EMPLOYEES
   1. Equity compensation benefit
   2. Employee compensation benefit expense
   3. Directors' emoluments
6. EQUITY
   1. Share capital
   2. Other reserves
7. TAXATION
   1. Income tax expense
   2. Deferred taxation
8. NON-CURRENT ASSETS CLASSIFIED AS HELD FOR SALE
9. RELATED PARTIES
10. ACCOUNTING FRAMEWORK
    1. Basis of preparation
    2. Going concern
    3. Standards, amendments and interpretations not yet effective
    4. Other accounting policies
11. SUBSEQUENT EVENTS